People diagnosed with advanced cancer can face a host of challenges and stresses, from navigating the health care system to dealing with relationship disruptions and figuring out how to spend the time […]
Study Advances Fertility Preservation Approach for Male Cancer Survivors
In a proof-of-concept study performed in primates, frozen immature testicular tissue has been successfully used for the conception and birth of a baby monkey. Although human trials are needed before the technique […]
Telephone-Based Rehab Program Helps People with Advanced Cancer Maintain Independence
As cancer progresses, it often leads to physical disability and pain that can threaten a person’s independence and devastate their quality of life. Yet most people with advanced cancer don’t receive physical therapy or engage […]
Artificial Intelligence Expedites Brain Tumor Diagnosis during Surgery
For patients with a brain tumor, the first step in treatment is often surgery to remove as much of the mass as possible. A tumor sample obtained and analyzed during surgery can […]
How the New York Institute of Beauty is Redefining Care for Cancer Patients
Medical professionals and researchers are continuously finding incredible breakthroughs in cancer treatment. As treatment options continue to progress, Linda Giardinello founder of New York Institute of Beauty, has identified a major gap in […]
Lynparza® Approval Brings New Hope for Pancreatic Cancer Patients
Pancreatic cancer made headlines throughout 2019 after both Jeopardy! host Alex Trebek and U.S. Congressman John Lewis were diagnosed with the devastating illness. Although curable when caught early, pancreatic cancer often does not cause symptoms […]
Mouse Study Points to Strategy for Preserving Bone During Chemotherapy
A new study in mice suggests that a biological process known as cellular senescence, which can be induced by cancer treatments, may play a role in bone loss associated with chemotherapy and […]
Remodeled CAR T-Cell Therapy Reduces Side Effects in First Clinical Trial
Over the course of several decades, NCI scientists laid extensive groundwork for a novel treatment that would eventually go on to become axicabtagene ciloleucel (Yescarta), a CAR T-cell therapy for adults with lymphoma. While the therapy […]